• Cost Of Lost Productivity Due To Premature, Suicide-Related Mortality In Poland

    Nov 1, 2016, 00:00

  • Measurement of Utilities by Time to Death Related to Advanced Non-Small Cell Lung Cancer in South Korea

    Nov 1, 2016, 00:00

  • Physicians’ Behavior Influences the Health and Economic Impact of Applying Circulating Tumor Cells as Response Marker in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2016, 00:00

  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00

  • Levonorgestrel Intrauterine System And Norethisterone For The Treatment of Chronic Abnormal Uterine Bleeding- A Randomized Clinical Comparison In The Patients of Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • How To Define Relevant Comparators In France? An Analysis Of The Economic Evaluations Submitted By Manufacturers And Reviewed By The Economic Committee (Ceesp) Of The French National Health Authority

    Nov 1, 2016, 00:00

  • Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe

    Nov 1, 2016, 00:00

  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00

  • Patience is a Virtue When Connecting Evidence Networks

    Nov 1, 2016, 00:00

  • Economic And Humanistic Burden of Chronic Spontaneous Urticaria In Brazil- Impact on Work Productivity, Resource Utilization And Quality of Life

    Nov 1, 2016, 00:00

  • The Health And Economic Burden of Obesity In Chile – An Epidemiological And Economic Simulation Model

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • Determination of Serum Carbamazepine Concentration Using Dried Blood Spot Specimens for Resource Limited Settings

    Nov 1, 2016, 00:00

  • Automation Of Hospital Medication Distribution Systems In The Us

    Nov 1, 2016, 00:00

  • The Role of Economic Evidence in Drug Reimbursement- South Korea

    Nov 1, 2016, 00:00

  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Treatment of Arm Fractures In Elderly Men And Women – A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Edoxaban Compared to Warfarin for The Treatment and Secondary Prevention of Venous Thromboembolism in The UK

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Carbapenem Versus Alternative Antibiotics For Urinary Tract Infection Due to Enterobacteriaceae Producing Esbl- A Systmatic Review

    Nov 1, 2016, 00:00

  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00

  • Impact of Obesity on Patient-Reported Outcomes after Total Knee Replacement

    Nov 1, 2016, 00:00

  • Market Access Agreements- What Impacts Drugs Purchasing in French Hospitals

    Nov 1, 2016, 00:00

  • Internal Consistency and Construct Validity of Patient-Reported Outcomes in Primary Progressive Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00

  • Application of Payment by Results Schemes in Oncology in Italy- Relation Between Timing for the Evaluation of Treatment Failures and Median Progression Free Survival (PFS) from Clinical Trials

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Visual Analogue Scale Foot And Ankle Instrument

    Nov 1, 2016, 00:00

  • High Demand For Post-Exposure Prophylaxis (PEP) For Consensual Sex Exposure Suggests A Need For Pre-Exposure Prophylaxis (PREP) In Uganda

    Nov 1, 2016, 00:00

  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00

  • Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Adapting to the Challenge- How are Innovative Study Designs Being used in Rare Diseases?

    Nov 1, 2016, 00:00

  • Building Intentions with the Theory of Planned Behaviour- The Mediating Role of Knowledge and Expectations in Successful New Pharmacy Public Health Services Implementation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00

  • A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

    Nov 1, 2016, 00:00

  • An Observational Study On Helath Related Quality Of Life In Diabetes Mellitus Patients

    Nov 1, 2016, 00:00

  • Risk Factors Influencing Cardiovascular Disease in Indian Women with Type 2 Diabetes Mellitus- A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00

  • Ongoing Analysis of Clinical and Economic Outcomes of Japanese Patients with Coronary Heart Disease Undergoing Percutaneous Coronary Intervention

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sulodexide in Patients with Non-Proliferative Diabetic Retinopathy in the Czech Republic

    Nov 1, 2016, 00:00

  • Patient-Reported Outcomes In Relapsed/Refractory Multiple Myeloma (Rrmm) In The Overall And Japanese Populations From Eloquent-2

    Nov 1, 2016, 00:00

  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00

  • Pro Instruments for Mental Disorders Used in Studies Published Since 2005- Which Diseases have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • Valuing Health- Results from the Health Auction Valuation Experiment (HAVE) Study

    Nov 1, 2016, 00:00

  • Practice Based outcome Research in Community Pharmacy

    Nov 1, 2016, 00:00

  • Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00

  • Productivity Loss In Patients Diagnosed With Spinal Stenosis And Lumbar Disc Herniation

    Nov 1, 2016, 00:00

  • Comparison Between the EQ-5D-5l and the EQ-5D-3l for General Population in China

    Nov 1, 2016, 00:00

  • Real World Data- Use of Novel Treatments and Biomarkers in Malignant Melanoma in European Countries

    Nov 1, 2016, 00:00

  • Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB)- Findings From In-Depth Qualitative Patient Interviews

    Nov 1, 2016, 00:00

  • Market Uptake Of Direct Oral Anticoagulants (Doacs) In Germany

    Nov 1, 2016, 00:00

  • Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt- A French Study

    Nov 1, 2016, 00:00

  • Is it Really Cost-Effective to Risk-Assess all Hospitalized Patients for Pressure Ulcers Every Nursing-Shift?

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Endoscopic Treatment with Radiofrequency Ablation for Patients with Barrett's Esophagus and High Or Low Grade Dysplasia in Spain

    Nov 1, 2016, 00:00

  • Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

    Nov 1, 2016, 00:00

  • My Opinions Matter! How Perspectives, Knowledge And Expectations Matter in Moderating the Success of New Pharmaceutical Services Implementation in Malaysia

    Nov 1, 2016, 00:00

  • Economic Impact of Fentanyl HCL Iontophoretic Transdermal System Versus IV PCA In Acute Pain Management Following Surgery In The United Kingdom, Germany And Sweden

    Nov 1, 2016, 00:00

  • The German Pain Practice Registry – A New Way to Use Real-Time Sampled Routine Data For Health-Care Research

    Nov 1, 2016, 00:00

  • A Cprd-Hes Database Study of Back Pain in the UK- Patient Pathways

    Nov 1, 2016, 00:00

  • Spinal Cord Stimulation Versus Conventional Medical Management for Failed Back Surgery Syndrome- A Dutch Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Number Of Patients In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis To Access The Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

    Nov 1, 2016, 00:00

  • Treatment of Hypertension in Elderly - Pharmacoeconomic Evaluation

    Nov 1, 2016, 00:00

  • A Cost Comparison of 1l Treatment Regimens for Metastatic Colorectal Cancer (MCRC) in Italy

    Nov 1, 2016, 00:00

  • Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...

    Nov 1, 2016, 00:00

  • Association Between Insulin Treatment and Breast Cancer Characteristics

    Nov 1, 2016, 00:00

  • Health- Related Quality of Life in Diabetic People with Different Cardiovascular Risks

    Nov 1, 2016, 00:00

  • The Nice Accelerated Access Review, How Does it Compare to The Dutch Conditional Reimbursement Pathway?

    Nov 1, 2016, 00:00

  • Utilisation of Antithrombotic Drugs in Slovakia

    Nov 1, 2016, 00:00

  • The Use of The Appraisal of Guidelines for Research and Evaluation Ii (AGREE II) Tool for Appraisal of Multiple Myeloma Treatment Guidelines

    Nov 1, 2016, 00:00

  • Association Between Body Mass Index Categories, Prevalence of Treated Type 2 Diabetes Mellitus, Total Healthcare Costs Among Patients Who Are Overweight or Obese

    Nov 1, 2016, 00:00

  • Access To Orphan Drugs In Poland - Is Change In Health Technology Assessment Approach Required?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Acupuncture Versus Standard Care For Pelvic And Low Back Pain In Pregnancy- An Analysis of The Game Randomized Trial

    Nov 1, 2016, 00:00

  • Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive Complaint

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Targeted Treatments for Pulmonary Arterial Hypertension (PAH) In Patients Receiving Active Treatments without Adequate Response

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Panitumumab in Patients of Metastatic Colorectal Cancer By Tumor Kras Status- A Systematic Review

    Nov 1, 2016, 00:00

  • Burden of Early and Advanced Breast Cancer in The Netherlands

    Nov 1, 2016, 00:00

  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Rates And Predictors Of Short Term Disability Claims Among Migraine Patients In The Us

    Nov 1, 2016, 00:00

  • Generic Drug Volume and Cost Savings in Oncology- A 2005-2014 Midas Analysis

    Nov 1, 2016, 00:00

  • Quality of Life in Relapsing Remmiting Multiple Sclerosis- Influence of Interferon Beta-1a (Avonex And Cinnovex) Treatment

    Nov 1, 2016, 00:00

  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00

  • Mapping the Prescription Trend for Rheumatoid Arthritis in Mumbai, India

    Nov 1, 2016, 00:00

  • Refining The Path to Personalized Medicine with Psychometric Analysis of Oral Cancer Biomarkers

    Nov 1, 2016, 00:00

  • Ticagrelor Treatment for Prevention of Cardiovascular Events in High Risk Post Myocardial Infarction Patients- Cost-Effectiveness Analysis Using Evidence From The Pegasus-Timi 54 Trial

    Nov 1, 2016, 00:00

  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00

  • Evaluation of Attitude and Perception of Retail Pharmacists Towards Patient Safety

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Lipegfilgrastim in Prophylaxis Of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00

  • Budget Impact Estimation of Changes In Reimbursement of Basal Insulin Therapies in Hungary

    Nov 1, 2016, 00:00

  • A Systematic Review of Treatment Patterns in Patients with Recurrent Glioblastoma in the Real World

    Nov 1, 2016, 00:00

  • The Impact Of Policy And Demographic Variables On Future Prescription Costs For A Publicly Funded Health Scheme In Ireland

    Nov 1, 2016, 00:00

  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00

  • Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries

    Nov 1, 2016, 00:00

  • Patterns of Medication Regimen Complexity Over One-Year Follow Up in Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00

  • The Burden of Staple Line Interventions in Colorectal Surgery Europe

    Nov 1, 2016, 00:00

  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00

  • G-BA Early Advice VS. EMA/HTA Parallel Advice from a German Perspective

    Nov 1, 2016, 00:00

  • Treatment Pattern Differences Across the United States, Western Europe, and Japan Among Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Antihypertensive Drugs Usage by Combination of ACEI – CCB and ACEI – Diuretic in Outpatient Hypertension Therapy at Rsal Mintohardjo Jakarta (July-November 2015)

    Nov 1, 2016, 00:00

  • Economic Aspects in the Treatment of Schizophrenia in Italy- Cost Consequences of an Early Long-Acting Injectable Antipsychotics (LAIS) Approach

    Nov 1, 2016, 00:00

  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00

  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00

  • Comparison of the Trends of Orphan Drugs Designations and Approvals in the United States and Europe In Oncology

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients with Chronic Hepatitis C Virus Genotype 1 in Iran

    Nov 1, 2016, 00:00

  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00

  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00

  • Compare Policies And Research Situation Of Rare Diseases And Orphan Drugs Between China And Other Countries

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • Incidence Cancer Costs Associated with Head And Neck (HN) Cancers- A Nationwide Study From France In 2008-2013 (EPICORL STUDY)

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of HDM Slit-Tablet For Allergen Immunotherapy In House Dust Mite Induced Allergic Rhinitis with or Without Allergic Asthma In An Italian Setting

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of A Flash Glucose Monitoring System for Patients with Diabetes Who Are Using Intensive Insulin

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of The Introduction of Generic Bosentan For The Treatment of Pulmonary Arterial Hypertension In Greece

    Nov 1, 2016, 00:00

  • A Real-World Evaluation of the Clinical and Economic Burden of United States Veteran Patients with Post-Traumatic Stress Disorder

    Nov 1, 2016, 00:00

  • Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty- the example of acute myocardial infarction

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Role of Clinical Pharmacist in Optimizing Reimbursement Originating from Performance-Based Risk-Sharing Arrangements- The Experience of the University Hospital “G. Martino” from Messina, Italy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Once-Yearly Injection of Zoledronic Acid For The Treatment of Osteoporosis In Japan

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Preferences For The Characteristics Of Home Enteral Nutrition (Hen) Via Tube Feeding- A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Global Value Dossiers (GVDS)- How to Ensure the Value Isn’t Lost in Translation

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines

    Nov 1, 2016, 00:00

  • Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

    Nov 1, 2016, 00:00

  • How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions- The Importance of Comparator Strategies

    Nov 1, 2016, 00:00

  • Economic Burden of Primary Immunodeficiency (PIDD) In Turkey

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Directly Eliciting Personal Utility Functions From A Convenience Sample Of 30 Health Outcomes Professionals- A Pilot Study

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications

    Nov 1, 2016, 00:00

  • Current Practice and Attitude Regarding off-Label Drug Use- A Survey of Oncology Practitioners

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Patterns of Index Biologic Drug Registrations To A Pharmacovigilance Register of Psoriasis Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective

    Nov 1, 2016, 00:00

  • Hospitalized Patients with Schizophrenia In Portugal- Clinical Characterization and Costs

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • HCV- Treat Ratio and Governance Footprints. Analysis of Regional Differences in Italy

    Nov 1, 2016, 00:00

  • Use of Antihypertensive Medications in Diabetic and Non-Diabetic Chronic Kidney Disease and Hemodialysis Patients- A Due Study

    Nov 1, 2016, 00:00

  • The 2016 US Payor Landscape- Results from a Survey of Medical and Pharmacy Directors on Formulary Management

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Surgical Excision Vs Mohs Micrographic Surgery for Non-Melanoma Skin Cancer

    Nov 1, 2016, 00:00

  • Direct Cost Analysis and Cost Effectiveness Analysis of Chronic Obstruction Pulmonary Disease in Fatmawati Public Hospital

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • The Impact of Surgical Professional Education- A Review of Clinical and Economic Outcomes

    Nov 1, 2016, 00:00

  • A Conceptual Framework for Tackling Market Access Challenges in Asia

    Nov 1, 2016, 00:00

  • Screening Rate for Diabetic Retinopathy and Macular Edema in Patients with Diabetes and their Treatment Costs in the United Arab Emirates

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • Heparin and Related Substances for Treating Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • The Organisational Analysis of “Patient Diagnostic Therapeutic Pathway” For Patients with Gastric Cancer In 5 Centres of The Veneto Region (Italy)

    Nov 1, 2016, 00:00

  • Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • Oab in Poland - This is Time for A Change

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization in Patients Receiving Pembrolizumab or Docetaxel with Previously Treated Advanced NSCLC

    Nov 1, 2016, 00:00

  • The Reduction Of Ceiling With The Eq-5d-5l Increases With Age In The General Adult Population

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Platinum Plus Paclitaxel Versus Platinum Plus Cyclophosphamide Among Patients with Early-Stage Ovarian Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Perception of Japanese Encephalitis Among Healthcare Students of Medicine, Pharmacy and Dentistry of A Private University in Malaysia

    Nov 1, 2016, 00:00

  • Impact of Surgical Technique on Length Of Stay and Early Outcomes in Breast Reconstruction- A Preliminary Analysis

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cervical Cancer Screening Strategies in China

    Nov 1, 2016, 00:00

  • Gestational Diabetes Screening for Chinese Women- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Assessment of Proton Pump Inhibitors Consumption in Ukraine in Comparison with other Countries of The World

    Nov 1, 2016, 00:00

  • The Economic Burden of Myocardial Infarction in Latin America

    Nov 1, 2016, 00:00

  • Macro-Economic Considerations in Healthcare Decision Making

    Nov 1, 2016, 00:00

  • To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?

    Nov 1, 2016, 00:00

  • Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden

    Nov 1, 2016, 00:00

  • Market Potential Of A New Infliximab Biosimilar In The European Market- A Budget Impact Analysis In France, Italy And The Uk

    Nov 1, 2016, 00:00

  • The Impact of Pharmacist Intervention on Medication Errors In A Teaching Hospital Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment- A Series of Case Studies with Decision Makers Across European Countries

    Nov 1, 2016, 00:00

  • Clinico-Economic Evaluation of Combined Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting

    Nov 1, 2016, 00:00

  • Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution- A Case Study of Erenumab in Episodic Migraine

    Nov 1, 2016, 00:00

  • Resource use and Associated Costs for Metastatic Squamous Non-Small Cell Lung Cancer (SQ NSCLC) Patients- A Retrospective Chart Review in Select European Countries

    Nov 1, 2016, 00:00

  • Requirements for Economic Evidence Across Different HTA Bodies

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Results in Significant Reductions in Annualized Relapse Rate (Arr) and Protective Effect on Disibiltiy Progression- Results From a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Evaluation of Patients Undergoing Hemodialysis At a Tertiary Care Centre

    Nov 1, 2016, 00:00

  • How Assessment Methods May Affect The Efficiency Of Appraisal Process- A Critical Review

    Nov 1, 2016, 00:00

  • Assessing The Cost-Utility of Etelcalcetide- A Markov Model

    Nov 1, 2016, 00:00

  • Understanding Methodological Differences Between and The Appropriate Application of Oncology Value Frameworks in Healthcare Decision-Making

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation And Cost Of Parkinson’s Disease In The United Kingdom

    Nov 1, 2016, 00:00

  • Real World Evidence In Decision-Making Processes On Public Funding Of Drugs In Poland

    Nov 1, 2016, 00:00

  • Association Between Subjective Well-Being and Health Status Among the Elderly in China- The Influences of Social Support and Social Adjustment

    Nov 1, 2016, 00:00

  • Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm)- Patients Perspective In Ths Spanish Health Care System

    Nov 1, 2016, 00:00

  • The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Attitudes Adherence and Barriers Among Puplicly Employed GPS Towards Evidence Based Medicine and Clinical Practice Guidelines in Cyprus

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation Study of Sildenafil in a Tertiary Care Teaching Hospital in India – A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Access To Innovative Medicines In The Czech Republic- Length Of Price And Reimbursement (PR) Procedures

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada

    Nov 1, 2016, 00:00

  • Assessment of Decisions and Cost-Effectiveness Criteria Considered by Seven Health Technology Assessment Agencies

    Nov 1, 2016, 00:00

  • Comparison of Caregiver-Rated 3-Level Euroqol-5d (Eq-5d-3l) and Health Utilities Index Mark 3 (Hui3) in Patients with Dementia in Singapore

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted By Absenteeism Associated with Sclerosis Multiplex In Poland

    Nov 1, 2016, 00:00

  • Predictors of Response to Interferone/Ribavarin Combination Therapy in Chronic Hepatitis C Virus Infection at Upper Egypt

    Nov 1, 2016, 00:00

  • Predictive Validity of National Nosocomial Infection Surveillance (NNIS) and Study on the Efficacy of Nosocomial Infections (SENIC) Risk Indexes for the Incidence of Surgical Site Infections (SSI) in General Surgery at Hospital Universiti S ...

    Nov 1, 2016, 00:00

  • Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D- Results From Assure-Csu Study

    Nov 1, 2016, 00:00

  • Knowledge and Perception of Medicine, Dentistry and Pharmacy Students of Malaysian University Regarding Ebola Virus Disease (EVD)

    Nov 1, 2016, 00:00

  • Effects of Medical Marijuana Legalization on Marijuana Use Among Adolescents and Adults In The United States

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • Value of Individually Prepared Drugs for Health System

    Nov 1, 2016, 00:00

  • Humanistic and Economic Outcomes of Pharmacist-Provided Medication Reviews in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • 1) Value of The Clinical Decision Support System For Adverse Drug Event Prevention- A Cost-Effectiveness Analysis And Cost-Benefit Analysis

    Nov 1, 2016, 00:00

  • Health Economic Costing Methods and Reporting in Austria

    Nov 1, 2016, 00:00

  • Analysis of Pharmacy Claims for High Cost Oncology Products- Abiraterone and Enzalutamide Usage in Mcrpc in Ireland

    Nov 1, 2016, 00:00

  • Burden of Illness in Patients with Elevated High-Sensitivity C-Reactive Protein Levels and a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Indirect Comparison of Triamcinolone Acetonide with Ranibizumab and Aflibercept for the Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Economic Burden of Diseases In Poland

    Nov 1, 2016, 00:00

  • Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

    Nov 1, 2016, 00:00

  • Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Development, Validation, and Pilot Testing of Metabolic Syndrome Quality of Life Questionnaire (Tapmetsqol)

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the Netherlands

    Nov 1, 2016, 00:00

  • Cost And Resource Utilization Among Multiple Sclerosis Patients With Increasing Disability In Latin America

    Nov 1, 2016, 00:00

  • Systematic Review of Budget Impact Analysis on Vaccines

    Nov 1, 2016, 00:00

  • French Health Policies- Front Runner for Early Access to Innovation

    Nov 1, 2016, 00:00

  • Supplementing the Right Way- Effective Cost Management of Multivitamin Syrups in a Paediatric Hospital

    Nov 1, 2016, 00:00

  • The Impact of Inflammatory Bowel Disease on Work Productivity- Comparison of A Real-World Sample Of Patients With Crohn's Disease And Ulcerative Colitis

    Nov 1, 2016, 00:00

  • Using Social Finance to Fund Generic Drug Repurposing for Rare Diseases- A Social Impact Bond Proof of Concept

    Nov 1, 2016, 00:00

  • Health Technology Assessment Considerations of The Primary Care Model Programme

    Nov 1, 2016, 00:00

  • Capacity for Endoscopic Screening for Gastric Cancer in Japan

    Nov 1, 2016, 00:00

  • Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial

    Nov 1, 2016, 00:00

  • Efficacy of Palbociclib Combinations Versus Endocrine Therapies in Advanced/ Metastatic Breast Cancer- Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Translatability Evaluation of the Rome IV Diagnostic Questionnaire for Adults

    Nov 1, 2016, 00:00

  • Drug Utilization in an Outpatient Private Paediatric Setting- An Observational Study

    Nov 1, 2016, 00:00

  • Burden of Diverticular Disease- An Observational Analysis Based on Italian Real World Data

    Nov 1, 2016, 00:00

  • Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong Kong

    Nov 1, 2016, 00:00

  • New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Pharmacist Intervention During Therapeutic Drug Monitoring Program In Saudi Arabia

    Nov 1, 2016, 00:00

  • Utilization And Cost Of Antimicrobials Used In Medicine And Surgery Departments Of A Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Primary Non-Adherence, Early Non-Persistence, Treatment Reinitiation and Long-Term Adherence Among A Population-Based Cohort of Naïve Patients Prescribed Antiosteoporotics

    Nov 1, 2016, 00:00

  • Review of National Health Technology Assessment Reports on Treatment of Severe Haemophilia A

    Nov 1, 2016, 00:00

  • Health State Utilities Associated with Post-Surgical Staphylococcus Aureus Infection

    Nov 1, 2016, 00:00

  • Launching Novel Antibiotics- Access Opportunities and Resistance in European Markets

    Nov 1, 2016, 00:00

  • Insulin Degludec in Clinical Practi A Systematic Review of Japanese Real-World Data

    Nov 1, 2016, 00:00

  • High-Risk Medications and Unplanned Hospitalizations- A Case–Time–Control Study

    Nov 1, 2016, 00:00

  • Resource Use In Idiopathic Pulmonary Fibrosis- Influence of Disease Progression and Exacerbations

    Nov 1, 2016, 00:00

  • Treatment Comparative Effectiveness In Rare Diseases- The Case of Transthyretin Familial Amyloid Polyneuropathy Survival

    Nov 1, 2016, 00:00

  • Assessment Of Core Drug Use Indicators Using Who/Inrud Methodology At Primary Health Care Centers In Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

    Nov 1, 2016, 00:00

  • A Systematic Review of The SF-36® Health Survey for Measuring Health-Related Quality of Life In Patients with Ulcerative Colitis

    Nov 1, 2016, 00:00

  • An Update of Real-World Cost-Utility Evaluation of Multiple Myeloma Treatments In Stem Cells Transplant Patients

    Nov 1, 2016, 00:00

  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Nov 1, 2016, 00:00

  • Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)

    Nov 1, 2016, 00:00

  • What's New in the Guidelines for Submission of Dossier for Listing into the Ministry of Health Medicines Formulary (Mohmf) ?

    Nov 1, 2016, 00:00

  • Cholesterol Management in the US

    Nov 1, 2016, 00:00

  • Market Access Routes for Orphan Oncology Drugs- How do Health Systems Help Patients Receive Treatments that are not Cost-Effective?

    Nov 1, 2016, 00:00

  • Analyzing a German Index for the EQ-5D-5L Based on Experienced Health

    Nov 1, 2016, 00:00

  • Comparison of Methods to Assess the Relative Importance of Criteria in Multi-Criteria Decision Analysis- An Evaluation of Orphan Drugs in Russia

    Nov 1, 2016, 00:00

  • Facing Challenges for a Cost Comparison of Day Surgical and Inpatient Varicose Vein Surgery

    Nov 1, 2016, 00:00

  • From The Unified Parkinson’s Disease Rating Scale (UPDRS) To The EQ-5D Utility Index- Development of A New Mapping Algorithm In Parkinson’s Disease (PD)

    Nov 1, 2016, 00:00

  • Cardiovascular Event Rates in Patients with High Cardiovascular Risk in the United Kingdom

    Nov 1, 2016, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Granulocyte Colony-Stimulating Factor (G-Csf) as Adjunctive Therapy in Cancer Patients with Established Febrile Neutropenia

    Nov 1, 2016, 00:00

  • Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis- Results of A Belgian Observational Non-Interventional ...

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC patients? A Meta-Analysis and Indirect Comparison on the Efficacy of First-Line Tyrosine Kinase Inhibitors

    Nov 1, 2016, 00:00

  • Drug Utilisation of Braf Inhibitors for Melanoma in Ireland

    Nov 1, 2016, 00:00

  • Will Stem Cells For Heart Failure Be The Next Sofosbuvir Issue?

    Nov 1, 2016, 00:00

  • The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015

    Nov 1, 2016, 00:00

  • Oncologists` Views on Reimbursement and Value of Cancer Drugs in Bosnia and Herzegovina

    Nov 1, 2016, 00:00

  • Caesarean Section In Xindu County of Chengdu, China- Trend And Its Correlates From 2008 to 2014

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris

    Nov 1, 2016, 00:00

  • Comorbidity of Depression And Type 2 Diabetes- A Retrospective Japanese Claims Database Analysis

    Nov 1, 2016, 00:00

  • Multimorbidity and Health Care Service Utilization in the Australian Workfor Findings From the National Health Survey

    Nov 1, 2016, 00:00

  • The Current Status And Influential Factors of Insulin Pen Needle Reuse In T2D Patients From China

    Nov 1, 2016, 00:00

  • Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Users of Primary Care in Brazil

    Nov 1, 2016, 00:00

  • Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Romanian Claw-Back Taxation- From A Financial Solution to A Challenge for Patients Access to Drugs

    Nov 1, 2016, 00:00

  • The Role and Impact of Evidence Review Group Analyses in the Nice Single Technology Assessment (STA) Process

    Nov 1, 2016, 00:00

  • Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany

    Nov 1, 2016, 00:00

  • Long-Term Health Care Cost in Patients with Symptomatic Peripheral Artery Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the United States

    Nov 1, 2016, 00:00

  • Budgetary Impact Analysis of Reimbursement Varenicline in the Smoking Cessation Treatment of Patients with Major Depression in Spain

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00

  • Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)

    Nov 1, 2016, 00:00

  • The Social Cost of Major Depression

    Nov 1, 2016, 00:00

  • A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00

  • Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00

  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00

  • Economic Evaluations of Haemophilus Influenzae Type B Vaccine- A Systematic Review

    Nov 1, 2016, 00:00

  • Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes

    Nov 1, 2016, 00:00

  • Cardiovascular Safety of Saxagliptin In Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analysis

    Nov 1, 2016, 00:00

  • Missed Opportunities in The Netherlands- The Negligence of Non-Statistical Uncertainty in Ced Policy

    Nov 1, 2016, 00:00

  • Expert Elicitation- Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?

    Nov 1, 2016, 00:00

  • A Study of Prescription Pattern of Non Steroidal Anii-Inflammatory Drugs in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Faecal Calprotectin as A Diagnostic Marker of Inflammatory Bowel Disease in Patients with Gastrointestinal Symptoms - is It Cost-Effective Procedure in Primary Care in Poland?

    Nov 1, 2016, 00:00

  • Qualitative Research Approaches In Rare Diseases- Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and Caregivers

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Health State Utility Values in Mulitple Myeloma

    Nov 1, 2016, 00:00

  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00

  • Dispensing Patterns of Vaccines by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Adoption of Managed Entry Agreements in Established and Emerging Markets

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine (CAM) Disclosure to the Health Care Providers- A Qualitative Insight from Malaysia Thalassemia Patients

    Nov 1, 2016, 00:00

  • Exploring Interest in The Use of A Complementary Therapy Among Individuals With Copd

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For France, Germany, Italy, Spain And United Kingdom

    Nov 1, 2016, 00:00

  • Adherence To Vancomycin Therapeutic Guidelines At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Economic Burden of Rheumatoid Arthritis In Italy- Possible Consequences on Early Rapidly Progressing Patients

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Children with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Costs of Multiple Myeloma Management And Treatment For Elderly Patients Who Are Not Transplant Candidates In The Serbian Health Care System

    Nov 1, 2016, 00:00

  • Self-Care Behavior And Medication Use Of Buddhist Monks With Diabetes Mellitus In Phasi Charoen, Bangkok

    Nov 1, 2016, 00:00

  • PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?

    Nov 1, 2016, 00:00

  • Oral Versus Intravenous Iron Treatment in Patients with Inflammatory Bowel Disease and Iron Deficiency and/or Anemia in Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Insulin Glargine in the Management of Type 1 and Type 2 Diabetes Mellitus from the Spanish National Health System Perspective

    Nov 1, 2016, 00:00

  • Influencing Factors On Knowledge, Attitude And Behaviour Towards Antibiotic Usage Among Adults In Ho Chi Minh City, Viet Nam

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Peg-L-Asparginase Versus E.Coli L-Asparaginase in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients- A Jordanian Perspective

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Antipsychotic Therapy Results in A Better Treatment Continuity Compared to A One-Monthly or Bi-Weekly Treatment In Schizophrenia

    Nov 1, 2016, 00:00

  • Conceptual Model and Clinical Outcomes Assessments for Angelman’s Syndrome- Utilizing Pragmatic Methods in Rare Diseases

    Nov 1, 2016, 00:00

  • The Predirtion of The Brca1/2-Related Ovarian Cancer Morbility In Russia

    Nov 1, 2016, 00:00

  • How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

    Nov 1, 2016, 00:00

  • The Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors For Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Country Trends that May Impact the Commercial Opportunity of New High Cost Treatments in the USA, EU5, Japan and Brazil

    Nov 1, 2016, 00:00

  • International Pediatric Hospital Patient Outcomes

    Nov 1, 2016, 00:00

  • Effects of Hbsag Positivity During Pregnancy on Adverse Maternal Outcomes- A Retrospective Database Analysis

    Nov 1, 2016, 00:00

  • Using Geographical Information Systems To Describe Quality Of Life As A Function Of Distance In Cancer Patients

    Nov 1, 2016, 00:00

  • The Number Of Cases In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

    Nov 1, 2016, 00:00

  • The Stool Antigen Test For Detection of Helicobacter Pylori For Diagnose H.Pylori Infection And Assessment of Eradication Therapy

    Nov 1, 2016, 00:00

  • Prescribing Patterns of Opioids Dispensed by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population

    Nov 1, 2016, 00:00

  • Why Should We Focus on A Structured Model of Secure Digital Exchanges To Incorporate New Documents In Electronic Patient Records?

    Nov 1, 2016, 00:00

  • Risk and Burden of Subsequent Fractures After First Osteoporosis-Related Fracture Among Osteoporosis Patients in Tianjin, China

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • Suggestion on Critical Illness Insurance in China

    Nov 1, 2016, 00:00

  • Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective

    Nov 1, 2016, 00:00

  • Estimating the Appropriate Price Discounts for Biosimilars in the Treatment of Rheumatoid Arthritis in the Nordic Setting Using an Excel-Based Interactive Tool

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Cost of Type 2 Diabetes in Urban Indian Population

    Nov 1, 2016, 00:00

  • Iron Deficiency Anemia In Pregnant Women In Fran A Prospective Cohort Study

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Improved Influenza Vaccination Coverage in Adults Aged 60 Years and Older in Beijing, China

    Nov 1, 2016, 00:00

  • Cost-Utility of Prophylaxis VS. On-Demand Treatment In Severe Haemophilia A Patients

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • Understanding the Relationship Between Effectiveness and Outcome Indicators in Health Care

    Nov 1, 2016, 00:00

  • Implementation of Adverse Event Trigger Tool System for Assessing Patient Safety

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • Which Types of Economic Evaluations are Considered by Health Technology Assessment Agencies?

    Nov 1, 2016, 00:00

  • Using Advanced Modeling To Identify The Factor Structure of The Improved Health Activities Questionnaire

    Nov 1, 2016, 00:00

  • How Much Does An Asthma-Related Event Cost In A Malaysian Suburban Hospital?

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of Adult Patients with Advanced Soft Tissue Sarcoma Previously Treated in Spain- Pazopanib vs. Trabectedina

    Nov 1, 2016, 00:00

  • Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature- A Comparison Of Text Mining And Manual Sifting Techniques

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Impact of Potential Drug Interactions in Cardiac Patients on Morbidity Risk- An Observational Prospective Approach

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Challenges For Securing Reimbursement And Access To Cdx In The Eu

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Heart Failure Patients in Korea

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • Patients' Educational Background was Associated with the Validity and Reliability of a Health-Related Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Systemic Sclerosis- Feasibility and Construct Validity of Eq-5d

    Nov 1, 2016, 00:00

  • Comparison Of Estimated Effectiveness Of Biologics For Rheumatoid Arthritis (Ra) In Large Insurance Databases Using A Claims-Based Algorithm

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Non-Surgical Treatment of Morbid Obesity In Poland

    Nov 1, 2016, 00:00

  • Economic Benefits of Cpap Treatment for Obstructive Sleep Apnea in The Elderly

    Nov 1, 2016, 00:00

  • Cost Per Responder Analysis of Sucrofferric Oxhydroxide Versus Sevelamer Carbonate in Patients on Hemodialysis in Europe

    Nov 1, 2016, 00:00

  • Bariatric Surgery Versus Non-Surgical Treatment of Morbid Obesity- A Systematic Review

    Nov 1, 2016, 00:00

  • Fabrication of Anti-Vitiligo Ointment Containing Psoralia Corylifolia- Invitro and Invivo Characterization

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • Integration of HIV Aids Program Intervention into Universal Health Coverage (UHC) - Lesson Learned from Indonesia

    Nov 1, 2016, 00:00

  • Multithreading- Turbocharged Cost-Effectiveness Analyses in Microsoft Excel

    Nov 1, 2016, 00:00

  • Widening Engagement with HTA Though open online Learning

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Acarizax® In Patients with House Dust Mites Induced Allergic Asthma And Allergic Rhinitis In Slovakia

    Nov 1, 2016, 00:00

  • The Economic Burden of Hepatitis C In France And Romania

    Nov 1, 2016, 00:00

  • A Review on the Current Status of Health Economic Modeling in Personalized Medicine

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV

    Nov 1, 2016, 00:00

  • Presence of Lipohypertrophy and its Relation to Insulin Injection Practices in Patients with Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Adoption of Innovative Technologies and Substitution Effects- Computed Tomographic Coronary Angiography In Australia

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015

    Nov 1, 2016, 00:00

  • Viewpoints of Thalassaemia Patients on the Combination of Traditional CM) with the Conventional Thalassaemia Treatment-A Qualitative Understanding Approach

    Nov 1, 2016, 00:00

  • Efficacy of The Fixed Combination of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Vs Traditional Topical Treatment In Psoriasis- A Bayesian Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness

    Nov 1, 2016, 00:00

  • Horizontal and Vertical Financial Equity in Hospitalized Cardiovascular Patients; A Case Study in Iran

    Nov 1, 2016, 00:00

  • Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine

    Nov 1, 2016, 00:00

  • Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Population Screening for Haemochromatosis In Australia- A State-Transition Model

    Nov 1, 2016, 00:00

  • Health Outcomes Assessment and Treatment Regimens For Patients with Gastric Cancer in Shanghai China

    Nov 1, 2016, 00:00

  • Secukinumab In The Management of Psoriatic Arthritis In Gree A Budget Impact Analysis

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »